← Eichor
Study identifier: NCT07298824 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

Condition: Myopia Progressing  ·  Sponsor: Second Affiliated Hospital of Nanchang University

PhasePhase 2
Planned participants164
Who can joinAll sexes, 3 Years to 18 Years
Healthy volunteersNo

About this study

To investigate whether probiotic MR-61 can assist in slowing down the progression rate of myopia (a prospective randomized controlled study).

This description comes directly from the study's public registry record.

Talk to the study team

Yifeng Yu, Ph.D  ·  13979180258  ·  171018170@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

Yifeng YuNanchang, Jiangxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07298824